Loss of heterozygosity on chromosome 9 and p16 (MTS1,CDKN2) gene mutations in esophageal cancers

International Journal of Cancer

Volumn 72, Issue 1, 1997, Pages 27-30

  Muzeau, Françoise ^a   Fléjou, Jean François ^a,b   Thomas, Gilles ^c   Hamelin, Richard ^c  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; NUCLEOTIDE; PROTEIN P16;

ADENOCARCINOMA; ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 9; CONTROLLED STUDY; ESOPHAGUS CANCER; EXON; FEMALE; GENE; GENE DELETION; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 1842331467     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970703)72:1<27::AID-IJC3>3.0.CO;2-6     Document Type: Article

References (23)

1. BARRETT, M.T., GALIPEAU, P.C., SANCHEZ, C.A., EMOND, M.J. and REID, B.J., Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene, 12, 1873-1878 (1996).
2. CAIRNS, P., MAO, L., MERLO, A., LEE, D.J., SCHWAB, D., EBY, Y., TOKINO, K., VAN DER RIET, P., BLAUGRUND, J.E. and SIDRANSKY, D., Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-417 (1994).
3. ESTÉVE, A., MARTEL-PLANCHE, G., SYLLA, B.S., HOLLSTEIN, M., HAINAUT, P. and MONTESANO, R., Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas. Int. J. Cancer, 66, 301-304 (1996).
4. GLEESON, C.M., SLOAN, J.M., MCGUIGAN, J.A., RITCHIE, A.J. and RUSSEL, S.E.H., Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res., 55, 3406-3411 (1995).
5. GLEESON, C.M., SLOAN, J.M., MCGUIGAN, J.A., RITCHIE, A.J., WEBER, J.L. and RUSSEL, S.E.H., Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma. Cancer Res., 56, 259-263 (1996).
6. GYAPAY, G., MORISSETTE, J., VIGNAL, A., DIB, C., FIZAMES, C., MILLASSEAU, P., MARC, S., BERNARDI, G., LATHOP, M. and WEISSENBACH, J., The 1993-1994 Génethon human genetic linkage map. Nature (Genet.), 7, 246-339 (1994).
7. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J.-P.J., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
8. HOLLAND, E.A., BEATON, S.C., EDWARDS, B.G., KEFFORD, R.F. and MANN, G.J., Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma. Oncogene, 9, 1361-1365 (1994).
9. HUGOT, J.P., LAURENT-PUIG, P., GOWER-ROUSSEAU, C., CAILLAT-ZUCMAN, S., BEAUGERIE, L., DUPAS, J.-L., VAN GOSSUM, A., BONAITI-PELLIE, C., CORTOT, A. and THOMAS, G., Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn's disease. Amer. J. med. Genet., 52, 207-213 (1994).
10. IGAKI, H., SASAKI, H., TACHIMORI, Y., KATO, H., WATANABE, H., KIMURA, T., HARADA, Y., SUGIMURA, T. and TERADA, M., Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res., 55, 3421-3423 (1995).
11. KAMB, A., Cell-cycle regulators and cancer. Trends Genet., 114, 136-140 (1995).
12. LIU, Q., YAN, Y.-X., MCCLURE, M., NAKAGAWA, H., FUJIMURA, F. and RUTSGI, A.K., MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. Oncogene, 10, 619-622 (1995).
13. LUKAS, J., PARRY, D., AAGAARD, L., MANN, D.J., BARTKOVA, J., STRAUSS, M., PETERS, G. and BARTEK, J., Retinoblastoma-protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature (Lond), 375, 503-506 (1995).
14. MAESAWA, C., TAMURA, G., NISHIZUKA, S., OGASAWARA, S., ISHIDA, K., TERASHIMA, M., SAKATA, K., SATO, N., SAITO, K. and SATODATE, R., Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res., 56, 3875-3878 (1996).
15. MORI, T., MIURA, K., AOKI, T., NISHIHIRA, T., MORI, S. and NAKAMURA, Y., Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/ cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3397 (1994).
16. MUZEAU, F., FLÉJOU, J.-F., POTET, F., BELGHITI, J., THOMAS, G. and HAMELIN, R., Profil des mutations du gène p53 et expression anormale de la protéine p53 dans les deux formes de cancer de l'œsophage. Gastroenterol. clin. Biol., 20, 430-437 (1996).
17. INK4 in human cancer. Proc. nat. Acad. Sci. (Wash.), 91, 11045-11049 (1994).
18. POLLOCK, P.M., PEARSON, J. V. and HAYWARD, N.K., Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer, 15, 77-88 (1996).
19. REED, A.L., CALIFANO, J., CAIRNS, P., WESTRA, W.H., JONES, R.M., KOCH, W., AHRENDT, S., EBY, Y., SEWELL, D., NAWROZ, H., BARTEK, J. and SIDRANSKY, D., High frequency of p16 (CDKN2/MTS-1/INK-4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56, 3630-3633 (1996).
20. SERRANO, M., HANNON, G.J. and BEACH, D.A., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
21. SUZUKI, H., ZHOU, X., YIN, J., LEI, J., JIANG, H.Y., SUZUKI, Y., CHAN, T., HANNON, G.J., MERGNER, W., ABRAHAM, J.M. and MELTZER, S.J., Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. Hum. mol. Genet., 4, 1883-1887 (1995).
22. TARMIN, L., YIN, J., ZHOU, X., SUZUKI, H., KRASNA, M. and MELTZER, S.J., Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus. Cancer Res., 54, 6094-6096 (1994).
23. ZHOU, X., TARMIN, L., YIN, J., JIANG, H.-Y., SUZUKI, H., RHYU, M.-G., ABRAHAM, J.M. and MELTZER, S.J., The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene, 9, 3737-3741 (1994).